Pharmacists Addressed Obesity Care Strategies

Experts detailed evolving treatment methods at a recent pharmacy forum in Boston.

Updated on Sept. 28, 2026 in Weight Loss

Gouache-painted editorial illustration of a glass beaker with a single capsule and a green apple, representing medical and lifestyle care.
Pharmacy specialists at the New England Institute of Ambulatory Care Pharmacists forum detailed new, personalized obesity management strategies integrating medication and lifestyle. AI Illustration. Upload story photo >

Live Poll

Do you believe personalized medical treatment for obesity is more effective than standardized approaches?

Clinical pharmacy specialists Vicki Saengkheune and Bola Olagunju presented new strategies for obesity management at the 2026 New England Institute of Ambulatory Care Pharmacists Annual Forum. The presentation emphasized tailoring treatments to individual patient needs.

Why it matters

Obesity is deeply linked to numerous comorbidities, making effective, individualized management critical for improving overall patient health outcomes. Personalized approaches that integrate medication with lifestyle changes remain essential to care.

Clinical site data covers a 3-year history of patient outcomes since the program began operations using liraglutide in 2023. These findings represent a case study in managing patient transitions and treatment adherence.

The players

Vicki Saengkheune

She is an ambulatory clinical pharmacy specialist at Beth Israel Lahey Health.

Bola Olagunju

He is an ambulatory clinical pharmacy specialist at Beth Israel Lahey Health.

New England Institute of Ambulatory Care Pharmacists

This professional organization hosted the 2026 Annual Forum in Boston.

Beth Israel Lahey Health

This healthcare system serves patients across Massachusetts and employs the featured specialists.

The details

The presenters explained how pharmacists act as educators to help patients understand the connections between obesity and other health conditions. Clinical strategies now involve using oral weight loss agents alongside physical activity as viable alternatives to injectable medications.

Timeline

  1. The clinical site initiated its weight management program in 2023.

  2. The NEIAP Annual Forum took place in Boston on September 28, 2026.

The Big Picture

The clinical guidance shared at the forum follows the introduction of Triple-G agents, which are currently transforming the obesity treatment landscape. This shift represents a move toward more diverse pharmaceutical interventions that allow for greater patient customization.

Patients may now have access to a broader range of medication options, including oral agents that offer alternatives to injectables. Discussing personalized treatment plans with a pharmacist can help clarify how lifestyle changes and new medications affect specific comorbid conditions.

The takeaway

Effective obesity care requires a multifaceted approach that combines medical technology with dedicated patient education. Patients are encouraged to work closely with their pharmacists to navigate the rapidly expanding options for weight management.

Further reading

For more information on clinical approaches to weight management, visit the Weight Loss section.

Source note: This article includes information reported by Pharmacytimes.

Live Poll

Do you believe personalized medical treatment for obesity is more effective than standardized approaches?